Reif für die Praxis? – Die nicht-invasive Pränataldiagnostik aus dem Blut Schwangerer

Nach 20 Jahren Forschung ist es gelungen, einen Test zu entwickeln, mit dem ohne Risiken für das Ungeborene bestimmt werden kann, ob genetische oder chromosomale Störungen vorliegen.

• Literatur

• 1 Ferguson-Smith MA, Yates JWR. Maternal age-specific rates for chromosomal aberrations and factors influencing them: Report of a collaborative European study on 52 965 amnisocenteses. Prenat Diagn (Special Issue) 1984; 4-4
• 2 Holzgreve W. Ethik in der ppränatalen Medizin- geht sie voran oder läuft sie hinterher?. Editorial. Ther. Umschau 2006; 63: 681-682
• 3 Hahn S, Holzgreve W. Fetal cells and cell free DNA in maternal blood: new insights into preeclampsia. Hum Reprod Update 2002; 6: 501-508
• 4 Holzgreve W, Hahn S, Zhong XY et al. Genetic communication between fetus and mother: short- and long-term consequences. Am J Obstet Gynecol 2007; 196: 372-381
• 5 Bischoff FZ, Hahn S, Johanson KL et al. Intact fetal cells in maternal plasma. Lancet 2003; 361: 139-140
• 6 Lo YMD, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487
• 7 Lun FMF, Tsui NB, Chan KC et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on maternal DNA in maternal plasma. PNAS 2008; 105: 19920-19925
• 8 Zhong XY, Hahn S, Holzgreve W. Prenatal identification of fetal genetic traits. Lancet 2001; 357: 310-311
• 9 Li Y, Hahn S, Holzgreve W. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation. Ann NY Acad Sci 2006; 1092: 285-292
• 10 Huang DJ, Nelson MR, Holzgreve W. Maldi-TOF-Mass spectrometry for trisomy detection. Methods Mol Biol 2008; 444: 123-132
• 11 Mergenthaler-Gatfield S, Holzgreve W, Hahn S. Spectral karyotyping (SKY) applications in prenatal diagnositics. Methods Mol Biol 2008; 444: 3-26
• 12 Zweifelhofer T, Tynan J, Cagasan L et al. Multiplexed massively parallel sequencing for the prenatal detection of fetal aneuploidy from maternal plasma. SCMM optimization study . Poster presented at the 2010 Annual Meeting of the American Society of Human Genetics (ASHG), Washington DC.
• 13 Chiu RWK, Akolehar R, Zheng YWL et al. Noninvasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342: 7401-7401
• 14 Ehrich M, Deciu C, Zweifelhofer T et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011; 204: 1-11
• 15 Bianchi D, Platt L, Goldberg J, Abuhamad JA et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Am J Obstet Gynecol 2012; 206: 1-15
• 16 Ashoor A, Syndelaki A, Wagner M, Birdir C, Nicolaides K. Chromosome-selective sequencing of maternal plasma cell-free DNA for first trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 1-5
• 17 Palomaki GE, Kloza EM, Lambert-Messerlian GM et al. DNA sequencing of maternal plasma to detect Down's syndrome: an international clinical validation. Genet Med 2011; 13: 913-920
• 18 Palomaki G, Deciu C, Kloza EM et al. DNA Sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An International Collaborative Study. Genet Med 2012; 14: 296-305
• 19 Tschudin S, Holzgreve W, Conde N et al. Pregnant women's assessment and level of knowledge of prenatal counceling. Ultraschall Med 2009; 30: 157-162